Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Evaluation of Efficacy and Safety of Fexofenadine 180mg Tablets for 7 Days in the Treatment of Pruritic Skin Disease

NCT00261079 is registered in ClinicalTrials.gov with Handok Inc. as lead sponsor.

NCT NCT00261079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00261079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Evaluation of Efficacy and Safety of Fexofenadine 180mg Tablets for 7 Days in the Treatment of Pruritic Skin Disease
Lead sponsor
Handok Inc.
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2005
Completion date
October 31, 2006
Enrollment
435 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pruritus